Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Do neuroleptics impair learning in schizophrenic patients?

T R Cutmore1, R J Beninger

  • 1Department of Psychology, Queen's University, Kingston, Canada.

Schizophrenia Research
|May 1, 1990
PubMed
Summary

Neuroleptic medications, used to treat schizophrenia, may impair incentive learning but not stimulus-stimulus associative learning. This suggests potential impacts on behavior modification strategies for schizophrenia treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating a race model account of executive control in rats with the countermanding paradigm.

Neuroscience·2014
Same author

D-1 receptor involvement in reward-related learning.

Journal of psychopharmacology (Oxford, England)·2012
Same author

Double dissociation of the effects of haloperidol and the dopamine D3 receptor antagonist ABT-127 on acquisition vs. expression of cocaine-conditioned activity in rats.

The Journal of pharmacology and experimental therapeutics·2010
Same author

Increased GABAergic activity in the region of the pedunculopontine and deep mesencephalic reticular nuclei reduces REM sleep and impairs learning in rats.

Behavioral neuroscience·2010
Same author

Too much of a good thing? Elevated baseline sleep spindles predict poor avoidance performance in rats.

Brain research·2010
Same author

Focusing on symptoms rather than diagnoses in brain dysfunction: conscious and nonconscious expression in impulsiveness and decision-making.

Neurotoxicity research·2008

Area of Science:

  • Neuroscience
  • Psychiatry
  • Pharmacology

Background:

  • Dopamine (DA) is implicated in reward-related (incentive) learning.
  • Schizophrenia treatment involves neuroleptics, which are dopamine receptor blockers.
  • Neuroleptic use may potentially impair learning processes in schizophrenic patients.

Purpose of the Study:

  • To investigate the effects of neuroleptic medication on incentive learning versus stimulus-stimulus associative learning in schizophrenic individuals.
  • To determine if learning deficits in schizophrenia are related to psychiatric state or neuroleptic drug dosage.

Main Methods:

  • Experiment 1: Schizophrenic outpatients on haloperidol or flupenthixol and controls performed incentive and s-s learning tasks.
  • Brief Psychiatric Rating Scale (BPRS) administered to assess psychiatric state.

Related Experiment Videos

  • Experiment 2: Schizophrenic inpatients on various neuroleptics (converted to chloropromazine equivalency - CPZEQ) performed similar learning tasks.
  • Blood samples analyzed for prolactin levels; multiple regression used to assess drug dose effects.

    • Main Results:

    • Schizophrenic patients showed impairments in all learning tasks.
    • Impairments in s-s learning correlated with psychiatric state, while incentive learning deficits did not.
    • Higher prolactin levels observed in patients compared to controls.
    • Neuroleptic drug dose (CPZEQ or prolactin) significantly predicted impaired incentive learning, but not s-s associative learning.

    Conclusions:

    • Neuroleptic medications may impair incentive learning in schizophrenic patients, independent of psychiatric state.
    • Stimulus-stimulus associative learning appears less affected by neuroleptics.
    • Findings suggest that neuroleptic-induced deficits in incentive learning could inform behavior modification strategies in schizophrenia treatment.